Ivermectin for Covid-19

Amelia Carolina Sparavigna
2020 Zenodo  
Discussion of scholar papers published until end of June and beginning of July, 2020, on Ivermectin, and of news that we can find about its use for Covid-19. A list of clinical trials is also given. For what concerns scholar papers, we report among them a preprint posted on 10 June in MedRχiv, which concludes that Ivermectin was associated with lower mortality during treatment of Covid-19. From news, we consider in particular the case of Iquitos, capital city of the Loreto Region in Peru,
more » ... by May 25, Covid-19 cases and deaths had dropped notably. The formulation of ivermectin used in Peru is also discussed, in particular that of the oral solution disclosed by the Peruvian Government. A section about updating (8 July) is added to the discussion. We report also the preprint posted on 8 July in MedRχiv, showing the result of a clinical trial. The preprint tells in the conclusions that add-on use of Ivermectin is giving better results when compared to controls, in particular a significant shorter hospital stay.
doi:10.5281/zenodo.3936427 fatcat:swequdnrtnbefjkynae77teb4u